Recombinant Human MPC1 Protein，His & GST

MPC1 (Mitochondrial Pyruvate Carrier 1) is a crucial protein involved in the transport of pyruvate into mitochondria, a process vital for cellular metabolism and energy production. Understanding MPC1 is particularly significant in the context of metabolic diseases and cancer, where altered mitochondrial function and energy production pathways often play a critical role. Research has shown that MPC1 facilitates the entry of pyruvate into the mitochondria, thus linking glycolysis to the tricarboxylic acid (TCA) cycle. Mutations or reduced expression of MPC1 can lead to impaired mitochondrial metabolism, which has implications for conditions such as obesity, diabetes, and certain types of cancer, where tumor cells exhibit a preference for glycolysis over oxidative phosphorylation (the Warburg effect). As scientists continue to unravel the complexities of mitochondrial bioenergetics, the study of recombinant MPC1 proteins allows for a deeper understanding of its structural and functional properties. Investigating recombinant MPC1 can help clarify how pyruvate transport mechanisms influence energy balance within cells, possibly uncovering new therapeutic targets for metabolic disorders and cancer treatment. By harnessing advanced techniques in protein engineering and functional assays, researchers aim to elucidate the molecular underpinnings of MPC1 activity, thus contributing to the broader field of metabolic research and potential clinical applications.